Menu
Currency
GWAS Study

Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Sherva R, Baldwin CT, Inzelberg R et al.

21098978 PubMed ID
GWAS Study Type
5543 Participants
80 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SR
Sherva R
BC
Baldwin CT
IR
Inzelberg R
VB
Vardarajan B
CL
Cupples LA
LK
Lunetta K
BA
Bowirrat A
NA
Naj A
PM
Pericak-Vance M
FR
Friedland RP
FL
Farrer LA
Chapter II

Abstract

Summary of the research findings

Alzheimer's disease (AD) is highly prevalent in Wadi Ara despite the low frequency of apolipoprotein E ε4 in this genetically isolated Arab community in northern Israel. We hypothesized that the reduced genetic variability in combination with increased homozygosity would facilitate identification of genetic variants that contribute to the high rate of AD in this community. AD cases (n = 124) and controls (n = 142) from Wadi Ara were genotyped for a genome-wide set of more than 300,000 single nucleotides polymorphisms (SNPs) which were used to calculate measures of population stratification and inbreeding, and to identify regions of autozygosity. Although a high degree of relatedness was evident in both AD cases and controls, controls were significantly more related and contained more autozygous regions than AD cases (p = 0.004). Eight autozygous regions on seven different chromosomes were more frequent in controls than the AD cases, and 116 SNPs in these regions, primarily on chromosomes 2, 6, and 9, were nominally associated with AD. The association with rs3130283 in AGPAT1 on chromosome 6 was observed in a meta-analysis of seven genome-wide association study (GWAS) datasets. Analysis of the full Wadi Ara GWAS dataset revealed 220 SNP associations with AD at p ≤ 10⁻⁵, and seven of these were confirmed in the replication GWAS datasets (p < 0.05). The unique population structure of Wadi Ara enhanced efforts to identify genetic variants that might partially explain the high prevalence of AD in the region. Several of these variants show modest evidence for association in other Caucasian populations.

124 Isreali Arab cases, 142 Israeli Arab controls

Chapter III

Study Statistics

Key metrics and study information

5543
Total Participants
GWAS
Study Type
Yes
Replicated
1,930 European ancestry cases, 1,312 European ancestry controls, 931 European ancestry and Ashkenazi Jewish cases, 1,104 European ancestry and Ashkenazi Jewish controls
Replication Participants
European, Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
Israel
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.